MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Clinical features"

  • 2024 International Congress

    Longitudinal Assessment of Dystonic Symptoms in Rapid-Onset Dystonia-Parkinsonism: genetic dystonia symptoms vary over time

    I. Haq, V. Wheelock, L. Ozelius, B. Snively, E. Napoli, K. Sweadner, A. Brashear (Miami, USA)

    Objective: To clarify the temporal progression of symptoms in the rare genetic dystonia, ATP1A3 disease Background: The ATP1A3 gene encodes the neuronally ubiquitous α3 subunit…
  • 2024 International Congress

    Mutation of the ATP5F1A gene associated with dystonia, spasticity, myoclonus, cognitive impairment and epilepsy – a rare case report of a patient

    M. Danis, G. Krastev, J. Necpal, R. Jech, M. Zech (Trnava, Slovakia)

    Objective: We present a patient with generalized dystonia with spasticity, craniofacial dysmorphism and myoclonus on the left upper limb due to mutation of the ATP5F1A…
  • 2024 International Congress

    The Impact of Standardized Recommendations on the Management of Initial and Refractory Pediatric Status Dystonicus

    K. Yang, N. Alazri, L. Vogt, Z. Zaman, V. Quiroz, C. Gorodetsky, D. Ebrahimi-Fakhari (Boston, USA)

    Objective: To develop consensus recommendations for the assessment, triaging and management of pre-status dystonicus, status dystonicus, and refractory status dystonicus in children. Background: Status dystonicus…
  • 2024 International Congress

    Cervical dystonia after cerebellar stroke and medullary hemorrhage

    I. Sarac, H. Sarac, F. Borovecki, N. Henigsberg, Z. Kresic (Zagreb, Croatia)

    Objective: to present a patient who developed delayed secondary cervical dystonia after anterior medullary hemorrhage and ipsilateral cerebellar stroke. Background: Postroke dystonia is mostly associated…
  • 2024 International Congress

    Burden of Movements Disorders at Initiative Plus Center Hospital

    P. Kiatoko, K. Luse (KINSHASA, The Democratic Republic of the Congo)

    Objective: describe the socio-demographic, clinical characteristics and evolutionary profiles of patients followed for movement disorders Background: The DR Congo specialists in abnormal movements are rare,…
  • 2024 International Congress

    Cervical Dystonia Objectively Measured with Wearable Sensor System

    B. Dahlben, P. Mulcahey, S. Lee, A. Norain, R. Ghazi, N. Bukhari-Parlakturk (Durham, USA)

    Objective: To develop an objective measure for a dystonia subtype called cervical dystonia (CD) using a commercially available wearable sensor technology. Background: CD is a…
  • 2024 International Congress

    Challenges in Wilson disease management in a resource-limited country: a case report from a tertiary center

    M. Soares, M. Santiago, A. Simeão, H. Galvão, P. Fontana, F. Travassos, M. Ramalho, R. Mendonça (Recife, Brazil)

    Objective: To describe a Wilson disease (WD) case report with severe neurological manifestations who was successfully treated with zinc salt monotherapy, due to unavailability of…
  • 2024 International Congress

    Movement disorders in patients with central nervous system tuberculosis: A systematic review

    K. Acurio Ortiz, N. Pacheco-Barrios, A. Flores-Gavino, F. Váscones-Román, I. Calisaya-Madariaga, M. Guerrero-Yrene, W. Rios-Garcia, L. Quintana- Garcia, E. Urrea-Mendoza (Lima, Peru)

    Objective: We conducted a critical review of the literature on movement disorders (MD) in patients with central nervous (CNS) tuberculosis (TB), with the goal of…
  • 2024 International Congress

    Efficacy and Safety of DaxibotulinumtoxinA-lanm for Injection in Adults with Cervical Dystonia: Pooled Global Analysis of ASPEN-1 and ASPEN-1-CN

    D. Truong, H. Xingyue, A. Ellenbogen, J. Lingjing, K. Dashtipour, A. Patel, T. Gross, R. Kazerooni, C. Gallagher, F. Xiaojin, S. Yunan, G. Lei, W. Xinhua, D. Hollander (Riverside, USA)

    Objective: To evaluate the pooled efficacy and safety of 2 doses of DaxibotulinumtoxinA-lanm for injection (DAXI) for the treatment of cervical dystonia (CD) in 2…
  • 2024 International Congress

    Oromandibular Dystonia in Hashimoto Encephalopathy: An Unusual Association Not To Miss

    S. Jha (Kolkata, India)

    Objective: To describe a case of proven Hashimoto Encephalopathy presenting with oromandibular dystonia (OMD) and orofacial dyskinesias (OFD) Background: Neurologic manifestations of Hashimoto’s Encephalopathy (HE)…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 48
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley